La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Terns Pharmaceuticals Gestione
Gestione criteri di controllo 1/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Amy Burroughs
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | less than a year |
| Proprietà del CEO | n/a |
| Durata media del management | less than a year |
| Durata media del Consiglio di amministrazione | 3.7yrs |
Aggiornamenti recenti sulla gestione
Recent updates
We Think Terns Pharmaceuticals (NASDAQ:TERN) Can Afford To Drive Business Growth
Aug 18
Terns Pharmaceuticals (NASDAQ:TERN) Is In A Good Position To Deliver On Growth Plans
May 03Terns Pharmaceuticals (NASDAQ:TERN) Is In A Good Position To Deliver On Growth Plans
Jan 12We're Hopeful That Terns Pharmaceuticals (NASDAQ:TERN) Will Use Its Cash Wisely
Sep 29Companies Like Terns Pharmaceuticals (NASDAQ:TERN) Are In A Position To Invest In Growth
Jun 06Companies Like Terns Pharmaceuticals (NASDAQ:TERN) Are In A Position To Invest In Growth
Feb 21Companies Like Terns Pharmaceuticals (NASDAQ:TERN) Are In A Position To Invest In Growth
Oct 03Terns Pharmaceuticals: The Easy Money Has Been Made
Sep 20Terns Pharmaceuticals GAAP EPS of -$0.55 beats by $0.08
Aug 08Is Terns Pharmaceuticals (NASDAQ:TERN) In A Good Position To Deliver On Growth Plans?
Jun 14Companies Like Terns Pharmaceuticals (NASDAQ:TERN) Are In A Position To Invest In Growth
Mar 16We're Not Very Worried About Terns Pharmaceuticals' (NASDAQ:TERN) Cash Burn Rate
Nov 24We're Hopeful That Terns Pharmaceuticals (NASDAQ:TERN) Will Use Its Cash Wisely
Aug 24Terns Pharma gains 9% on positive TERN-101 data in mid-stage NASH study
Jun 14AMMINISTRATORE DELEGATO
Amy Burroughs (54 yo)
less than a year
Mandato
Ms. Amy L. Burroughs, M.B.A., serves as CEO & Director at Terns Pharmaceuticals, Inc. from February 07, 2024. She serves as Independent Director of Tenaya Therapeutics, Inc. since December 2022. She had be...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CFO & Treasurer | 4yrs | US$3.14m | 0.033% $ 185.5k | |
| COO, General Counsel & Secretary | 3.8yrs | US$3.08m | 0.033% $ 185.5k | |
| CEO & Director | less than a year | Nessun dato | Nessun dato | |
| Chief Legal Officer | less than a year | Nessun dato | Nessun dato | |
| Senior VP & Head of Research | 2.6yrs | Nessun dato | Nessun dato | |
| Chief Medical Officer | 1.3yrs | Nessun dato | Nessun dato | |
| Chief Business Officer | less than a year | Nessun dato | Nessun dato | |
| Chief Development Officer | less than a year | Nessun dato | Nessun dato |
0.9yrs
Durata media
46.5yo
Età media
Gestione esperta: Il team dirigenziale di TERN non è considerato esperto (durata media 0.9 anni), il che suggerisce un nuovo team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | less than a year | Nessun dato | Nessun dato | |
| Independent Director | 5.8yrs | US$298.99k | 0% $ 0 | |
| Independent Director | 3.7yrs | US$304.99k | 0% $ 0 | |
| Independent Director | 4.3yrs | US$299.99k | 0% $ 0 | |
| Member of Scientific Advisor | no data | Nessun dato | Nessun dato | |
| Independent Chairman | 3.7yrs | US$340.15k | 0% $ 0 | |
| Member of Scientific Advisor | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisor | no data | Nessun dato | Nessun dato | |
| Independent Director | 2.1yrs | US$303.06k | 0% $ 0 | |
| Member of Scientific Advisor | no data | Nessun dato | Nessun dato | |
| Independent Director | 3.7yrs | US$480.49k | 0% $ 0 | |
| Independent Director | 2.9yrs | US$302.49k | 0% $ 0 |
3.7yrs
Durata media
56.5yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di TERN sono considerati esperti (durata media dell'incarico 3.7 anni).